Psychiatry and Neurology, Neurology · Knoxville, TN
NPI
1699773747
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2727 Asbury Rd Ste 101102
Knoxville, TN, 37914
Phone (716) 948-6754
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
1,801 services
Medicare patients, 2024
190
Average age 65
Drug cost, 2024
$5.6M
6,055 prescriptions
Company payments, 2025
$2,906
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad I Hussain was code A9579 (injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml), 585 times for 31 patients. In total Mohammad I Hussain billed 1,801 services in 35 codes, and Medicare paid $63K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 585 | 31 | $1.18 | $690 |
| 99214 Office E&M - Established | Office | 134 | 88 | $71.75 | $9,615 |
| 99204 Office E&M - New | Office | 99 | 99 | $115.18 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 97 | 83 | $11.98 | $1,162 |
| 96138 Behavioral Health Services | Office | 90 | 88 | $24.14 | $2,172 |
| 96132 Behavioral Health Services | Office | 90 | 88 | $95.79 | $8,621 |
| 99483 Office/Outpatient Services | Office | 58 | 58 | $206.58 | $12K |
| 80053 Clinical Chemistry | Office | 42 | 37 | $9.88 | $415 |
| 95886 Electrical Nerve Conductivity | Office | 38 | 14 | $73.40 | $2,789 |
| 36415 Venipuncture Blood Collection | Office | 31 | 27 | $7.85 | $243 |
| 70553 MRI/MRA - Head and Neck | Office | 30 | 30 | $161.79 | $4,854 |
| 85025 Blood Count | Office | 21 | 20 | $6.96 | $146 |
By year: 2022 $67K for 1,860 services; 2023 $69K for 2,289 services; 2024 $63K for 1,801 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 42 | 37 | $9.88 | $415 |
| 36415 Venipuncture Blood Collection | 31 | 27 | $7.85 | $243 |
| 85025 Blood Count | 21 | 20 | $6.96 | $146 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad I Hussain prescribed most often to Medicare patients was Donepezil Hcl, with 609 prescriptions and refills. In total Mohammad I Hussain wrote 6,055 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 609 | 1,001 | 233 | $3,591 |
| Topiramate Generic | 340 | 551 | 113 | $2,394 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 263 | 465 | 95 | $6,046 |
| Gabapentin Generic | 261 | 315 | 101 | $3,400 |
| Levetiracetam Generic | 229 | 354 | 69 | $6,151 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 224 | 328 | 78 | $2,283 |
| Memantine Hcl Generic | 207 | 340 | 72 | $4,933 |
| Sumatriptan Succinate Generic | 173 | 204 | 62 | $2,093 |
| Lamotrigine Generic | 167 | 236 | 44 | $2,989 |
| Primidone Generic | 165 | 243 | 50 | $4,587 |
| Clonazepam Generic | 116 | 116 | 35 | $1,565 |
| Amitriptyline Hcl Generic | 110 | 167 | 30 | $1,679 |
| Ropinirole Hcl Generic | 106 | 189 | 37 | $2,701 |
| Oxcarbazepine Generic | 100 | 143 | 37 | $4,843 |
| Qulipta Atogepant | 98 | 98 | 21 | $110K |
Brand drugs: - claims; generic drugs: 4,915 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad I Hussain $2,906 ($2,906 in general payments such as food, travel and fees) from 24 companies. The largest payer was UCB, Inc. with $492.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.